Proposed Escalation Strategy A theoretical cagrilintide and retatrutide combination protocol might follow this gradual escalation approach: Weeks 1-4: Foundation Phase Cagrilintide: 0.6 mg weekly Retatrutide: 2 mg weekly Focus: Establishing tolerance to both compounds Monitoring: Gastrointestinal effects, appetite changes Weeks 5-8: Escalation Phase Cagrilintide: 1.2 mg weekly Retatrutide: 4 mg weekly Focus: Increasing receptor activation Monitoring: Weight changes, metabolic markers Weeks 9-12: Optimization Phase Cagrilintide: 2.4 mg weekly Retatrutide: 8 mg weekly Focus: Approaching therapeutic targets Monitoring: Comprehensive metabolic assessment Weeks 13+: Maintenance Phase Cagrilintide: 3.0-4.5 mg weekly Retatrutide: 8-12 mg weekly Focus: Sustained metabolic effects Monitoring: Long-term safety and efficacy This graduated approach mirrors the successful strategies used in cagrilintide 10mg research protocols, where slow escalation minimizes side effects while building therapeutic benefit
The sooner treatment begins, the better the outcome
Glutathione FAQ How many treatments do I need
You Could Benefit from GHK-Cu Injections GHK-Cu injections may be a supportive option if youre noticing changes in your skin or hair with age, recovering from a procedure or injury, or feeling like your body isnt bouncing back the way it used to
10.3389/fphar.2019.01529 121 WangQ
Hayashi Y, Shi SH, Esteban JA, Piccini A, Poncer JC, Malinow R (2000)
